...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New shares issued?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

hummm,,,no matter what,,,either way,,,DM has to go public with ZCC !!! Why are waiting in the wings as a private and inaccessible entity to its existing shareholders and future shareholders???..jmo

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply